Biological characterisation of breast cancer by means of PET. (Q35764576)

10 August 2017

1 reference

title

Biological characterisation of breast cancer by means of PET. (English)

1 reference

10 August 2017

1 reference

Andreas K Buck

1

1 reference

10 August 2017

Holger Schirrmeister

series ordinal

2

1 reference

10 August 2017

Torsten Mattfeldt

series ordinal

3

1 reference

10 August 2017

Sven N Reske

series ordinal

4

1 reference

10 August 2017

4 May 2004

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

10 August 2017

1 reference

10 August 2017

31 Suppl 1

1 reference

10 August 2017

S80-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1529-6

10 August 2017

0 references

cites work

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

1 reference

12 December 2020

3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

1 reference

12 December 2020

BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.

1 reference

12 December 2020

Hypoxia-Induced increase in FDG uptake in MCF7 cells

1 reference

12 December 2020

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

1 reference

12 December 2020

Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method

1 reference

12 December 2020

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

1 reference

12 December 2020

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

12 December 2020

Differential diagnosis of lung tumor with positron emission tomography: a prospective study

1 reference

12 December 2020

Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival

1 reference

12 December 2020

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.

1 reference

12 December 2020

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

12 December 2020

Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction

1 reference

12 December 2020

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

12 December 2020

Prognostic significance of bone metastasis from breast cancer

1 reference

12 December 2020

Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.

1 reference

12 December 2020

Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study

1 reference

12 December 2020

Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years

1 reference

12 December 2020

Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase

1 reference

12 December 2020

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer

1 reference

12 December 2020

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer

1 reference

12 December 2020

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

1 reference

12 December 2020

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

12 December 2020

Intra-tumoural microvessel density in human solid tumours.

1 reference

12 December 2020

Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions

1 reference

12 December 2020

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography

1 reference

12 December 2020

Prognostic factors in breast cancer: current and new predictors of metastasis

1 reference

12 December 2020

Expression of hexokinase II and Glut-1 in untreated human breast cancer

1 reference

12 December 2020

The clinical course of bone metastases from breast cancer

1 reference

12 December 2020

Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings

1 reference

12 December 2020

Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture

1 reference

12 December 2020

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.

1 reference

12 December 2020

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose

1 reference

12 December 2020

Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.

1 reference

12 December 2020

Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.

1 reference

12 December 2020

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

1 reference

12 December 2020

Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies

1 reference

12 December 2020

POSITRON EMISSION TOMOGRAPHY FOR IN-VIVO MEASUREMENT OF REGIONAL BLOOD FLOW, OXYGEN UTILISATION, AND BLOOD VOLUME IN PATIENTS WITH BREAST CARCINOMA

1 reference

12 December 2020

Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?

1 reference

12 December 2020

Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.

1 reference

12 December 2020

Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

1 reference

12 December 2020

FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers

1 reference

12 December 2020

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

1 reference

12 December 2020

Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography

1 reference

12 December 2020

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1: mechanisms and consequences

1 reference

12 December 2020

Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.

1 reference

12 December 2020

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

1 reference

12 December 2020

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

12 December 2020

Characterization of 18F-FDG uptake in human endothelial cells in vitro

1 reference

12 December 2020

Cellular release of [18F]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system.

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020

Understanding the utility of adjuvant systemic therapy for primary breast cancer.

1 reference

12 December 2020

10.1007/S00259-004-1529-6

Identifiers

DOI

1 reference

release_n3bcc453snbi7pkb52brwpbs4e

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n3bcc453snbi7pkb52brwpbs4e

24 November 2022

mapped directly with Wikidata item

1 reference